Sarah Lewis
Family · San Antonio, TXNPI 1982184370
Payments from drug & device makers
Across 102 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$227
- Mayne Pharma Commercial LLC$194
- Biogen$191
- Hologic Sales And Service, LLC$158
- Astellas Pharma US Inc$145
- Exeltis, USA Inc.$126
- plus $812 from 21 others
What the payments were for
- Food & beverage$1,75595%
- Education$995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $227 |
| Mayne Pharma Commercial LLC | 13 | $194 |
| Biogen | 13 | $191 |
| Hologic Sales And Service, LLC | 6 | $158 |
| Astellas Pharma US Inc | 3 | $145 |
| Exeltis, USA Inc. | 8 | $126 |
| Organon | 10 | $104 |
| Johnson & Johnson | 1 | $99 |
| Merck | 4 | $70 |
| Sanofi | 1 | $65 |
| Sumitomo Pharma America, Inc. | 4 | $65 |
| Coopersurgical, Inc. | 2 | $65 |
| Pacira Pharmaceuticals Incorporated | 3 | $51 |
| Evofem Biosciences, Inc. | 4 | $50 |
| Dexcom, Inc. | 2 | $42 |
| Pfizer | 3 | $40 |
| Exact Sciences | 1 | $24 |
| Millicent US Inc | 1 | $18 |
| Novartis | 1 | $17 |
| Lupin Inc. | 1 | $16 |
| Agile Therapeutics, Inc. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
| Avion Pharmaceuticals | 1 | $13 |
| Ascend Therapeutics US, LLC | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $12 |
| Aspira Women's Health Inc | 1 | $11 |
| Meditrina | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$103
How this compares
$1,854 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 17 | $2,552 |
Paid to pharmacies, not to this prescriber.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Ayoade AvworoSan Antonio$111K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.